Hemostemix (CVE:HEM) Reaches New 52-Week High – Should You Buy?

Hemostemix Inc. (CVE:HEM – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as C$0.12 and last traded at C$0.12, with a volume of 60720 shares changing hands. The stock had previously closed at C$0.13. Hemostemix Price Performance The firm has a market […]

Leave a Reply

Your email address will not be published.

Previous post Insight Wealth Strategies LLC Boosts Stake in iShares Core S&P 500 ETF (NYSEARCA:IVV)
Next post Qifu Technology (NASDAQ:QFIN) Stock Price Down 5.2% – Should You Sell?